SCHEMBL200588

SCHEMBL200588

OB(O)c1ccnc(Cl)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RECQL P46063 1/20 0.47
LOX P28300 1/20 0.42
LOXL3 P58215 1/20 0.42
LOXL2 Q9Y4K0 1/20 0.42
ENPP2 Q13822 4/20 0.41
TTR P02766 1/20 0.41
TRPA1 O75762 1/20 0.38
SMARCA2 P51531 2/20 0.38
SMARCA4 P51532 2/20 0.38
PLG P00747 1/20 0.37
F12 P00748 1/20 0.37
F11 P03951 1/20 0.37
KLKB1 P03952 1/20 0.37
PRSS1 P07477 1/20 0.37
PRSS2 P07478 1/20 0.37
PRSS3 P35030 1/20 0.37
TDP1 Q9NUW8 1/20 0.36
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
KDM4E B2RXH2 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29717267 1.00 RECQL (0.47) RECQLLOXLOXL3LOXL2ENPP2
SCHEMBL29950674 0.83 IDO1 (0.46) RECQLLOXLOXL3LOXL2TTR
SCHEMBL9224607 0.76 CCR1 (0.42) ENPP2TTRPLGF12F11
SCHEMBL30151430 0.76 CCR1 (0.42) ENPP2TTRPLGF12F11
SCHEMBL1404632 0.74 ENPP2 (0.38) ENPP2TTRPLGF12F11
SCHEMBL13921938 0.74 ENPP2 (0.43) ENPP2TTRPLGF12F11
SCHEMBL8870 0.73 UHRF1 (0.50) ENPP2SMARCA2SMARCA4PLGF12
SCHEMBL18319188 0.73 CA1 (0.41) ENPP2TTRPLGF12F11
SCHEMBL1462938 0.73 NOS3 (0.46) ENPP2PLGF12F11KLKB1
SCHEMBL13453333 0.73 LOXL2 (0.42) LOXL2ENPP2TTRPLGF12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 970 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250194617-A1 Materials and Methods for Extending Shelf-Life of Foods JP LABORATORIES, INC. 2025-06-19 US claimed
US-20250169514-A1 Materials and Methods for Extending Shelf-Life of Foods JP LABORATORIES, INC. 2025-05-29 US claimed
US-20230380457-A1 Materials and Methods for Extending Shelf-Life of Foods JP LABORATORIES, INC. 2023-11-30 US claimed
EP-4280882-A2 MATERIALS AND METHODS FOR EXTENDING SHELF-LIFE OF FOODS JP LABORATORIES, INC. (US) 2023-11-29 EP claimed
US-20230363426-A1 Materials and Methods for Extending Shelf-Life of Foods JP LABORATORIES, INC. 2023-11-16 US claimed
US-11793220-B2 Materials and methods for extending shelf-life of foods JP LABORATORIES, INC. (US) 2023-10-24 US claimed
CN-116916755-A Materials and methods for extending the shelf life of food products JP实验室公司 2023-10-20 CN claimed
US-11737481-B2 Materials and methods for extending shelf-life of foods JP LABORATORIES, INC. (US) 2023-08-29 US claimed
US-11495769-B2 Inorganic light emitting diode and inorganic light emitting device including the same LG DISPLAY CO., LTD. (KR) 2022-11-08 US claimed
US-20220264914-A1 MATERIALS AND METHODS FOR EXTENDING SHELF-LIFE OF FOODS JP LABORATORIES, INC. 2022-08-25 US claimed
US-20220225647-A1 MATERIALS AND METHODS FOR EXTENDING SHELF-LIFE OF FOODS JP LABORATORIES, INC. 2022-07-21 US claimed
US-20220225646-A1 MATERIALS AND METHODS FOR EXTENDING SHELF-LIFE OF FOODS JP LABORATORIES, INC. 2022-07-21 US claimed
US-20210167321-A1 INORGANIC LIGHT EMITTING DIODE AND INORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME LG DISPLAY CO., LTD. (KR) 2021-06-03 US claimed
CN-115650982-B Compounds for imaging TAU protein aggregates AC免疫有限公司 2026-05-19 CN disclosed
US-20260132121-A1 INHIBITORS OF RIPK2 AND MEDICAL USES THEREOF ODYSSEY THERAPEUTICS INC (US) 2026-05-14 US disclosed
US-12624018-B1 Inhibitors of RIPK2 and medical uses thereof ODYSSEY THERAPEUTICS, INC. (US) 2026-05-12 US disclosed
WO-2005095400-A1 AZAINDOLES USEFUL AS INHIBITORS OF JAK AND OTHER PROTEIN KINASES VERTEX PHARMACEUTICALS INCORPORATED (US) 2005-10-13 WO disclosed
US-20050197338-A1 Substituted pyrazole urea compounds for the treatment of inflammation PHARMACIA AND UPJOHN COMPANY LLC 2005-09-08 US disclosed
EP-1568699-A1 1,3-DIHYDROIMIDAZOLE FUSED-RING COMPOUND Eisai Co., Ltd. (JP) 2005-08-31 EP disclosed
WO-2005037797-A1 SUBSTITUTED PYRAZOLE UREA COMPOUNDS FOR THE TREATMENT OF INFLAMMATION PHARMACIA CORPORATION (US) 2005-04-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260132121-A1 INHIBITORS OF RIPK2 AND MEDICAL USES THEREOF RIPK1, RIPK2, RIPK4 RECQL 789/4885LOX 1452/4885LOXL3 2509/4885
US-20050197338-A1 Substituted pyrazole urea compounds for the treatment of inflammation IL4, ARG2, CASP4 RECQL 1131/4885LOX 1849/4885LOXL3 1697/4885
US-12624018-B1 Inhibitors of RIPK2 and medical uses thereof RIPK2, RIPK1, RIPK4 RECQL 2460/4885LOX 2910/4885LOXL3 1182/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.